Device Trial Radar · NCT07503171
Hypoxia and Hemodilution Testing in Healthy Adult Volunteers
Last checked: Nov 20, 2026Latest source record: Mar 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
7
Planned (sponsor's estimate)
Start
Apr 2, 2026
Primary completion
Feb 1, 2027
Study completion Jan 31, 2028
Sponsor
- Lead sponsor
- Nihon KohdenNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 31, 2026
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 35 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will collect physiological measurements in healthy adult volunteers under controlled hypoxia and hemodilution conditions.
Conditions
- Hypoxia
- Hemodilution
Interventions
Noninvasive Physiological Monitoring DeviceDevice
Octopal R Noninvasive Pulse Wave Measuring Device DMO-8000X with TL 811S Finger Probe
Primary outcomes
What the sponsor says the trial is designed to measure.
- Collection of Hemoglobin and Oxygen Saturation MeasurementsTime frame: From enrollment to the end of treatment up to 8 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Vital Sign Research Group
San Francisco, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.